Compare Pfizer Inc (PFE) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Tripadvisor Inc Common Stock — how do they compare? Pfizer Inc trades at $24.94 (market cap $142.14B), while Tripadvisor Inc Common Stock trades at $13.79 (market cap $1.61B). The key difference: Pfizer Inc is far larger — about 88.3× Tripadvisor Inc Common Stock's market cap, and Pfizer Inc pays a 6.9% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals.
| PFE | TRIP | |
|---|---|---|
Market Cap | $142.14B | $1.61B |
Volume | 29,869,932 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $28.56 | $19.14 |
52-Week Low | $23.29 | $9.24 |
Enterprise Value | $192.80B | $1.73B |
Dividend Yield | 6.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.75, down 1.2% on the day, with a neutral technical outlook. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $0.75 beating expectations of $0.722. Pfizer demonstrates robust profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated from pandemic peaks. Recent news highlights the company's focus on AI drug discovery and pipeline development.
Pfizer presents a value opportunity trading below analyst consensus target of $28.25, with 38% of analysts rating it Buy. The stock offers a solid dividend yield with recent $0.43 payments. Key risks include patent expirations and revenue normalization post-COVID, while catalysts include obesity and oncology pipeline developments in 2026.
Tripadvisor (TRIP) trades at $13.8, down 5.35% over 24 hours. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators are neutral. Fundamentally, revenue grew to $1.89B in 2025 with a net income margin of 0.99%, but recent earnings misses and a high P/E of 131.09 raise valuation concerns. The recent $700M sale of TheFork to American Express simplifies the business and provides a cash infusion.
Outlook is mixed: the sale of TheFork and focus on core experiences offer strategic clarity, but stiff competition and macroeconomic pressures pose risks. Analyst consensus is a 'Hold' with a $13.87 price target, slightly above the current price, indicating limited near-term upside amid cautious sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →
